Free tool
Rate yourself against a role
Like a pilot's type rating, this checklist maps the competencies a psychedelic-therapy trial expects of a given role and medicine, then lets you mark where you stand. It is free to use, needs no account, and everything you enter stays in your browser.
This is a self-assessment for orientation and continuing-education preparation. It is not a credential and not an assessment by Blossom. The competency categories are drawn from the published psychedelic-therapy core-competency framework.
Looking for something specific? Ask Blossom
Build your checklist
The checklist below shows the competencies that trial guidance leans on most for a facilitator working with any protocol, ranked by how often clinical-trial guidance names them.
0 of 40 rated
Screening38 competencies
- Informed consent, decisional capacity, autonomy, and withdrawal rights
59 trial guidelines reference this
- Confidentiality, privacy, and research data protection
53 trial guidelines reference this
- Screening, eligibility, and readiness assessment
52 trial guidelines reference this
- Acute psychological response and emergency management during dosing
51 trial guidelines reference this
- Adverse event identification, documentation, and reporting
46 trial guidelines reference this
- General psychedelic-assisted practice skills
45 trial guidelines reference this
- Preparation and integration support
43 trial guidelines reference this
- Suicide and serious psychiatric risk assessment
41 trial guidelines reference this
- Manual fidelity, protocol adherence, and deviation management
39 trial guidelines reference this
- Post-dose follow-up, safety monitoring, and retention support
37 trial guidelines reference this
- Discharge readiness, escort safety, and post-session supervision
30 trial guidelines reference this
- Blinding, allocation concealment, and unblinding control
29 trial guidelines reference this
- Emergency recognition, escalation, and disposition planning
29 trial guidelines reference this
- Medication, substance-use, washout, and taper management
29 trial guidelines reference this
- Study documentation, data integrity, and regulatory recordkeeping
27 trial guidelines reference this
- Manualized psychedelic psychotherapy delivery
25 trial guidelines reference this
- Co-therapist and multidisciplinary team coordination
24 trial guidelines reference this
- Study record and trial registration literacy
24 trial guidelines reference this
- Therapeutic boundaries, professional conduct, and consent for touch
24 trial guidelines reference this
- Physical safety monitoring
19 trial guidelines reference this
- Acute psychiatric and behavioral risk monitoring
17 trial guidelines reference this
- Ethical conduct in human-subject research
16 trial guidelines reference this
- Preparation support
16 trial guidelines reference this
- Supportive nondirective therapeutic stance
16 trial guidelines reference this
- Good Clinical Practice and protocol procedure compliance
15 trial guidelines reference this
- Therapeutic alliance building
15 trial guidelines reference this
- Adverse effects and side-effect management
14 trial guidelines reference this
- Psilocybin session facilitation
14 trial guidelines reference this
- Hallucinogen pharmacology and effects
13 trial guidelines reference this
- Psychedelic-assisted psychotherapy preparation and integration
13 trial guidelines reference this
- Dissociation and acute neuropsychiatric effect monitoring
12 trial guidelines reference this
- Ketamine psychotherapy delivery
12 trial guidelines reference this
- Physiologic monitoring, thermoregulation, hydration, and overdose response
11 trial guidelines reference this
- Special-interest adverse event vigilance
11 trial guidelines reference this
- Depression symptom and remission monitoring
10 trial guidelines reference this
- Comprehensive psychiatric assessment
9 trial guidelines reference this
- Ensure confidentiality and session containment
9 trial guidelines reference this
- Outcome Measure and Assessment Literacy
9 trial guidelines reference this
Preparation2 competencies
- Grounding and regulation techniques
9 trial guidelines reference this
- Mindfulness, intention-setting, set and setting, and somatic presence
9 trial guidelines reference this
Your gap report
Rate the competencies below to see where you are confident and where the gaps sit.
Each competency page lists the courses that teach it, so you can turn a gap into a plan. Open any competency above to see who covers it.
Psychedelic-therapy competency self-assessment
| Date | |
| Role | Facilitator |
| Protocol family | All families |
| Progress | 0 of 40 rated |
Screening
| Informed consent, decisional capacity, autonomy, and withdrawal rights | Not rated |
| Confidentiality, privacy, and research data protection | Not rated |
| Screening, eligibility, and readiness assessment | Not rated |
| Acute psychological response and emergency management during dosing | Not rated |
| Adverse event identification, documentation, and reporting | Not rated |
| General psychedelic-assisted practice skills | Not rated |
| Preparation and integration support | Not rated |
| Suicide and serious psychiatric risk assessment | Not rated |
| Manual fidelity, protocol adherence, and deviation management | Not rated |
| Post-dose follow-up, safety monitoring, and retention support | Not rated |
| Discharge readiness, escort safety, and post-session supervision | Not rated |
| Blinding, allocation concealment, and unblinding control | Not rated |
| Emergency recognition, escalation, and disposition planning | Not rated |
| Medication, substance-use, washout, and taper management | Not rated |
| Study documentation, data integrity, and regulatory recordkeeping | Not rated |
| Manualized psychedelic psychotherapy delivery | Not rated |
| Co-therapist and multidisciplinary team coordination | Not rated |
| Study record and trial registration literacy | Not rated |
| Therapeutic boundaries, professional conduct, and consent for touch | Not rated |
| Physical safety monitoring | Not rated |
| Acute psychiatric and behavioral risk monitoring | Not rated |
| Ethical conduct in human-subject research | Not rated |
| Preparation support | Not rated |
| Supportive nondirective therapeutic stance | Not rated |
| Good Clinical Practice and protocol procedure compliance | Not rated |
| Therapeutic alliance building | Not rated |
| Adverse effects and side-effect management | Not rated |
| Psilocybin session facilitation | Not rated |
| Hallucinogen pharmacology and effects | Not rated |
| Psychedelic-assisted psychotherapy preparation and integration | Not rated |
| Dissociation and acute neuropsychiatric effect monitoring | Not rated |
| Ketamine psychotherapy delivery | Not rated |
| Physiologic monitoring, thermoregulation, hydration, and overdose response | Not rated |
| Special-interest adverse event vigilance | Not rated |
| Depression symptom and remission monitoring | Not rated |
| Comprehensive psychiatric assessment | Not rated |
| Ensure confidentiality and session containment | Not rated |
| Outcome Measure and Assessment Literacy | Not rated |
Preparation
| Grounding and regulation techniques | Not rated |
| Mindfulness, intention-setting, set and setting, and somatic presence | Not rated |
Self-assessment for orientation and continuing-education preparation. Not a credential and not an assessment by Blossom. Generated at moreblossom.com/clinical-guidelines/self-assessment.